Table 2. Relevance of Enhanced CT, 68Ga-PSMA-11 PET/CT and 18F-FDG PET/CT Parameters for Identification of Pathological Characteristics in ccRCC.
Pathological features | Radiological parameters | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Enhanced CT | 68Ga-PSMA-11 PET/CT | 18F-FDG PET/CT | ||||||||
CT value | ICCa | Pb value | SUVmax | ICCa | Pc value | SUVmax | ICCa | Pc value | ||
Tumor necrosis | 0.221 | <0.001 | 0.119 | |||||||
Negative | 128.97± 31.86 | 0.936 [0.895-0.961] | 17.39 (7.58-25.20) | 0.969 [0.949-0.982] | 3.97 (2.98-6.40) | 0.906 [0.848-0.943] | ||||
Positive | 141.08±32.87 | 0.929 [0.787-0.961] | 30.51 (26.18-32.54) | 0.898 [0.679-0.968] | 5.92 (3.32-6.81) | 0.922 [0.767-0.975] | ||||
Sarcomatoid or rhabdoid feature | 0.262 | <0.001 | 0.038 | |||||||
Negative | 129.86 32.66 | 0.937 [0.899-0.961] | 18.76 (8.91-26.93) | 0.971 [0.952-0.982] | 4.02 (3.03-6.79) | 0.907 [0.852-0.942] | ||||
Positive | 145.33± 23.48 | 0.895 [0.477-0.984] | 33.93 (32.54-35.33) | 0.837 [0.195-0.976] | 6.79 (5.45-8.04) | 0.914 [0.537-0.987] | ||||
Adverse pathology * | 0.179 | <0.001 | 0.049 | |||||||
Negative | 128.31±32.63 | 0.937 [0.894-0.962] | 14.94 (7.36-23.32) | 0.967 [0.944-0.981] | 3.69 (2.94-6.40) | 0.915 [0.859-0.949] | ||||
Positive | 140.35± 29.63 | 0.927 [0.811-0.973] | 31.55 (27.87-34.39) | 0.869 [0.683-0.950] | 5.59 (4.52-6.81) | 0.900 [0.745-0.963] |
Adverse pathology is defined as tumor presenting with necrosis or a sarcomatoid or rhabdoid feature
ICC: Data in the brackets are 95% confidence intervals
P values were calculated with Student's t test
P values were calculated with Mann-Whitney U test
ccRCC = clear-cell renal cell carcinoma; CT = computed tomography; ICC = Intraclass correlation coefficient; SUVmax = maximum standardized uptake value
Data are mean ± standard deviation for CT value, median (interquartile range) for SUVmax